Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double-blind, clinical trial to assess the efficacy and safety of fixed dose combination Dry Powder Inhaler of Glycopyrronium 12.5 I¼g/Formoterol Fumarate 12 I¼g/Fluticasone Propionate 250 I¼g in comparison with fixed dose dry powder inhaler Glycopyrronium 50 I¼g co-administered with fixed dose dry powder inhaler combination of Formoterol Fumarate 12 I¼g/Fluticasone Propionate 250 μg in patients with chronic obstructive pulmonary disease

Next Previous
Search
Trial Profile

A randomized, double-blind, clinical trial to assess the efficacy and safety of fixed dose combination Dry Powder Inhaler of Glycopyrronium 12.5 I¼g/Formoterol Fumarate 12 I¼g/Fluticasone Propionate 250 I¼g in comparison with fixed dose dry powder inhaler Glycopyrronium 50 I¼g co-administered with fixed dose dry powder inhaler combination of Formoterol Fumarate 12 I¼g/Fluticasone Propionate 250 μg in patients with chronic obstructive pulmonary disease

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluticasone-propionate/formoterol/glycopyrrolate (Primary) ; Formoterol/fluticasone propionate; Glycopyrrolate
  • Indications Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Glenmark Pharmaceuticals Ltd

    • Most Recent Events

    • 25 Feb 2020 Planned number of patients changed from 336 to 396.
    • 25 Feb 2020 Status changed from recruiting to completed.
    • 27 Sep 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top